Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1.
Published February 19, 2020 · Recall initiated: December 20, 2019
Summary
FDA records drug Class I recall D-0833-2020, published February 19, 2020 and initiated December 20, 2019. Recalling firm: Taro Pharmaceuticals U.S.A., Inc.; Status: Terminated; Lot: Lot #: 331771, Exp. June 2021. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
What to do
Voluntary: Firm initiated · Letter
Get an email if LAMOTRIGINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LAMOTRIGINE
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Distributor
- Nationwide in the U.S. and Puerto Rico.
- UPC
- 0351672413019
- Lot
- Lot #: 331771, Exp. June 2021
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TNAugust 17, 2022
- FDALamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDCJune 10, 2020
- FDAEthacrynate Sodium for Injection, USP, 50mg/vial, Single Dose Vial, Rx Only, Manufactured by: CadilaFebruary 19, 2020
- FDAVaginal Verification Panel Ref 8208 Lot 8208-11February 12, 2020
- FDALamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For:September 26, 2018
- FDALamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle, Rx only, Manufactured by: Unichem LaboratoriesOctober 5, 2016
Questions about this recall
Was Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1. recalled?
Yes. FDA published recall D-0833-2020 on February 19, 2020. Reported hazard: Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LAMOTRIGINE. UPC: 0351672413019.